Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11

MDLinx (April 15, 2022) – A third dose of the COVID-19 vaccine from Pfizer Inc and BioNTech produced significant protection against the Omicron variant of the coronavirus in healthy children ages 5 to 11, the companies said on Thursday.

Blood serum analysis of 30 pediatric participants who received a booster dose in a study showed a 36-fold increase in Omicron neutralizing antibodies, the drugmakers said.

Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11 | MDLinx